Skip to main content
See every side of every news story
Published loading...Updated

Sirolimus-Eluting Balloon Strategy Matches Drug-Eluting Stents in Large International PCI Trial

Summary by News Medical
New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates found that utilizing a strategy of sirolimus-eluting balloons with bailout stenting only if necessary was noninferior to routine drug-eluting stent (DES) implantation as part of the treatment for de novo coronary artery disease.

43 Articles

The Berkshire EagleThe Berkshire Eagle
+37 Reposted by 37 other sources
Center

Cordis Unveiled Breakthrough Results from SELUTION DeNovo and SELUTION4ISR Randomized Trials at TCT 2025, Transforming Coronary Artery Disease (CAD) Treatment Beyond Stenting

SELUTION DeNovo Trial - the largest randomized Drug Eluting Balloon trial - demonstrates a SELUTION SLR™ DEB strategy is non-inferior to a Drug Eluting Stent treatment strategy in de novo lesions.SELUTION4ISR, a randomized controlled trial, proves SELUTION SLR™ DEB is…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 78% of the sources are Center
78% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Charleston Gazette-Mail broke the news in Charleston, United States on Sunday, October 26, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal